SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA

NeuroThera’s Proprietary Cannabinoid-Enhanced Platform Targets Antibiotic Resistance Using Approved Antimicrobials TEL AVIV, ...
JD Supra

Cannabis in 2026 – Part II: Hemp Tightening in 2026—The Compliance Cliff, CBD Carve-Out Signals, and Business Risk

While federal marijuana policy trends toward less restrictive treatment, hemp faces a sharp regulatory contraction. Late 2025 legislation ...

Legislators advance bills to ban all or most ‘intoxicating hemp’ products in SC

Legislation banning or nearly banning hemp products infused with THC, providing an alternative high in a state where ...

Tilray: Rescheduling Rally Meets Equity Erosion & Short Interest Volatility

TLRY remains a Hold, despite the double digits international growth prospects and the potential synergy from its vertically ...
The Marijuana Herald

Breakdown of Over 500 Peer-Reviewed Cannabis Studies Published in the Past Year

Over the past 12 months, hundreds of peer-reviewed cannabis-related studies have been released, covering everything from pain ...